CD93 and neoplasm: This result contradicts the findings of Sun et al. Vemuri et al. suggest that administering an anti-CD93 neutralizing antibody to tumor-bearing mice, which disrupts the CD93 and IGFBP7 interaction, is associated with vascular normalization.